A detailed history of Smartleaf Asset Management LLC transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 306 shares of KALV stock, worth $2,741. This represents 0.0% of its overall portfolio holdings.

Number of Shares
306
Previous 79 287.34%
Holding current value
$2,741
Previous $951,000 297.06%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$9.46 - $15.39 $2,147 - $3,493
227 Added 287.34%
306 $3.78 Million
Q2 2024

Aug 13, 2024

BUY
$10.35 - $12.49 $817 - $986
79 New
79 $951,000

Others Institutions Holding KALV

About KalVista Pharmaceuticals, Inc.


  • Ticker KALV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,602,000
  • Market Cap $220M
  • Description
  • KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...
More about KALV
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.